Peter Yu
Fortuna: 5 M $ al 30/09/2026
Fortuna: 5 M $ al 30/09/2026
Peter Yu is currently the Chief Financial Officer, Director & Vice President at Qurient Co., Ltd. Prior to his current position, he worked as an Analyst at BNP Paribas Securities (Asia) Ltd. from 2013 to 2019.
He also served as the Head of Research at BNP Paribas Securities Korea Co., Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
QURIENT CO., LTD. 0,77 % | 29/07/2026 | 289.955 ( 0,77 % ) | 5 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| QURIENT CO., LTD. | Director Financiero/CFO | 01/08/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
BNP Paribas Securities (Asia) Ltd.
BNP Paribas Securities (Asia) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 04/07/2019 |
BNP Paribas Securities Korea Co., Ltd.
BNP Paribas Securities Korea Co., Ltd. Financial ConglomeratesFinance Provides financial services | Director de Investigación - Acciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
BNP Paribas Securities (Asia) Ltd.
BNP Paribas Securities (Asia) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
BNP Paribas Securities Korea Co., Ltd.
BNP Paribas Securities Korea Co., Ltd. Financial ConglomeratesFinance Provides financial services | Finance |
Qurient Co., Ltd.
Qurient Co., Ltd. BiotechnologyHealth Technology Engages in researching, developing, commercializing and selling of medicines | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.